Building an AI-Ready Biopharma Organization

About this episode

Scott Cenci discusses the impact of generative and agentic AI on the biopharma industry with Nagaraja Srivatsan.

Scott Cenci, chief information and data officer for Acadia Pharmaceuticals, sits down with Nagaraja Srivatsan to discuss how generative and agentic AI are reshaping biopharma throughout the enterprise from R&D and clinical development to the commercial field. He discusses how it is changing the roles of people like medical writers into medical editors, why every knowledge worker will soon manage AI agents as part of their job; and the hard problems leaders face in prioritizing AI investments, avoiding experiment fatigue, governing enterprise data, and building a culture of continuous learning.​

People in this episode

Host: Nagaraja Srivatsan

Guest: Scott Cenci

Topics covered

• AI in biopharma
• generative AI
• clinical development
• data governance
• continuous learning

Keywords

• AI
• biopharma
• R&D
• clinical development
• medical writers
• data governance
• continuous learning

Mentioned in this episode

Organizations: Acadia Pharmaceuticals

More episodes of Life Sciences DNA Podcast

• Lessons from Insmed’s Journey to an AI First Biotech · June 11, 2026 · 46 min
• Human Accountability in an Agentic Pharma World · May 28, 2026 · 49 min
• Making AI Transformations that Stick · May 14, 2026 · 53 min
• Finding ROI from AI in the Mundane · April 9, 2026 · 46 min
• A Pragmatic Path to AI-Enabled Commercial Operations · March 26, 2026 · 37 min
• Reimagining Scientific Work in the Age of AI Agents · March 12, 2026 · 47 min